|
LYST expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.47879486434022E-11 |
| Normal-vs-Stage2 |
7.64940000000935E-05 |
| Normal-vs-Stage3 |
2.62479999957321E-08 |
| Normal-vs-Stage4 |
1.66930000000676E-06 |
| Stage1-vs-Stage2 |
2.262000E-01 |
| Stage1-vs-Stage3 |
5.277200E-01 |
| Stage1-vs-Stage4 |
3.264200E-01 |
| Stage2-vs-Stage3 |
4.343000E-01 |
| Stage2-vs-Stage4 |
6.949800E-01 |
| Stage3-vs-Stage4 |
6.477600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62525548574877E-12 |
| Normal-vs-AfricanAmerican |
2.648600E-04 |
| Normal-vs-Asian |
3.600000E-02 |
| Caucasian-vs-AfricanAmerican |
9.344400E-01 |
| Caucasian-vs-Asian |
2.374000E-01 |
| AfricanAmerican-vs-Asian |
2.663000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.89148696705388E-12 |
| Normal-vs-Female |
4.4942938259851E-12 |
| Male-vs-Female |
4.371800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.879800E-03 |
| Normal-vs-Age(41-60Yrs) |
8.26427815070474E-12 |
| Normal-vs-Age(61-80Yrs) |
4.66260363651827E-12 |
| Normal-vs-Age(81-100Yrs) |
1.897760E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.402200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.727600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.364400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.020800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.121000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.509200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.798000E-04 |
| Normal-vs-Grade 2 |
8.86835049840329E-12 |
| Normal-vs-Grade 3 |
1.50629952955228E-10 |
| Normal-vs-Grade 4 |
3.27089999996311E-06 |
| Grade 1-vs-Grade 2 |
1.915770E-01 |
| Grade 1-vs-Grade 3 |
3.011400E-01 |
| Grade 1-vs-Grade 4 |
5.436600E-01 |
| Grade 2-vs-Grade 3 |
7.600000E-01 |
| Grade 2-vs-Grade 4 |
2.524600E-01 |
| Grade 3-vs-Grade 4 |
3.146600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.87228052242972E-14 |
| Normal-vs-ccB subtype |
5.79619999774295E-08 |
| ccA subtype-vs-ccB subtype |
9.506200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.32001093283907E-12 |
| Normal-vs-N1 |
2.465900E-02 |
| N0-vs-N1 |
7.409400E-01 |
|
|
